CMS Rule to Improve Medicare Part B Prescription Drug Models

This controversial rule could change how doctors profit from using the most expensive drugs – Washington Post

Medicare’s Cancer Drug Experiment Annoys Specialists – NBC

Read the CMS proposal here and related article from the Motley Fool  (9 Drugs That Cost Medicare a Fortune)

News over the weekend

At the start of the weekend,  Bloomberg reported that “UnitedHealth Group Inc., the largest U.S. health insurer, has decided to call it quits in two state Obamacare markets. The insurer won’t sell plans for next year in Georgia and Arkansas, according to state insurance regulators. ”

In a column report by the  Los Angeles Times   however,  mentioned “United, which makes most of its money in the large-group (employer) market, always was a reluctant participant in the individual exchanges, and was largely inept at pricing and managing those products. “